Wearable Device For Feeding and Observing Birds and Other Flying Animals
A device for feeding and observing flying animals comprising a hat, a support mounted on the hat and extending outward from the hat, and a feeder mounted on the support.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8207234 | Methods for treating diabetic foot ulcers The present invention provides methods and pharmaceutical formulations for treating diabetic foot ulcers. ... | 06/26/2012 |
| 8207233 | Methods for treating diabetic foot ulcers The present invention provides methods and pharmaceutical formulations for treating diabetic foot ulcers. ... | 06/26/2012 |
| 7250397 | Antiarrhythmic peptides Disclosed are novel peptides including antiarrhythmic peptides that have improved stability. Further disclosed are compositions that include such peptides and methods of using the compositions particularly as medicaments. ... | 07/31/2007 |
| 7109237 | Emulsion containing ascorbic acid and its uses in the cosmetics and dermatological fields A water-in-oil emulsion containing ascorbic acid and, as an emulsifier, a dimethiconecopolyol or an alkyldimethiconecopolyol, where the aqueous phase having a pH ranging from 5.5 to 7.5. This emulsion allows ascorbic acid to be stabilized and can be used, in particu... | 09/19/2006 |
| 6958159 | Pharmaceutical gel composition The present invention relates to an improved pharmaceutical composition useful for the topical treatment of burns, cuts, wounds, abrasions and the like, and to methods of treatment of injured body surfaces such as skin. ... | 10/25/2005 |
| 6932966 | Topically applied reconstituted ocean water mixture and method of producing and using the mixture A skin treatment mixture for treating pierced skin such as that resulting from a body piercing procedure includes sea salt, lysozyme and reconstituted ocean water. The reconstituted ocean water preferably is the product of reverse osmosis of water. The skin treatmen... | 08/23/2005 |
| 6828313 | Use of oxandrolone in the treatment of burns and other wounds The subject invention provides a method of treating burn-induced weight loss in a burn patient which comprises administering a therapeutically effective amount of an oxandrolone to the patient. The invention also provides a method of treating a wound in a patient su... | 12/07/2004 |
| 6767559 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present invention admixe... | 07/27/2004 |
| 6759436 | Clear micellized formulations of β-carotene and method of treating leukoplakia A clear aqueous formulation for topical application in the oral cavity of humans to treat leukoplakia contains water, β-carotene, a water miscible polyol, an unsaturated fatty acid ester, and a surfactant, preferably polyethoxylated castor oil. The formulation pref... | 07/06/2004 |
| 6696433 | Use of sex steroids function modulators to treat wounds and fibrotic disorders The present application relates to the use of compounds that influence the sex hormone system for the treatment of wounds and/or fibrotic disorders. Preferred compounds for use in such treatments are steroid hormones and especially the oestrogens.... | 02/24/2004 |
| 6669966 | Compositions for facilitating skin growth and methods and articles using same Skin-growth-enhancing compounds and compositions including a therapeutically effective amount of at least one electron active compound, or a pharmaceutically acceptable derivative thereof, that has at least two polyvalent cations, at least one of which ha... | 12/30/2003 |
| 6565895 | Bismuth compounds for the treatment and prevention of mucositis The invention relates to the unexpected discovery that bismuth-containing compounds are effective in the treatment of oral mucositis in a mammal. Thus, the invention relates, in one aspect to a method of treating oral mucositis comprising administering an... | 05/20/2003 |
| 6555125 | Lesion and ulcer medication Pharmaceutical compositions are provided which comprise effective amounts of antimicrobials, anti-inflammatories, and antihistamines, to provide an ulcer medication which prevents secondary infections and promotes healing while providing immediate relief ... | 04/29/2003 |
| 6506393 | Methods of treating protozoal diseases The invention concerns a new pharmaceutical agent for oral or topical administration in the treatment of protozoal diseases, in particular of leishmaniasis, which contains as the active substance one or several compounds having the general formula I ... | 01/14/2003 |
| 6492434 | Methods for inhibiting skin ulceration by use of cyanoacrylate adhesives A cyanoacrylate adhesive is applied onto intact surface skin areas prone to ulceration so as to inhibit formation of surface skin ulcers.... | 12/10/2002 |
| 6489317 | Method for eradication of Helicobacter pylori The invention provides methods for the treatment and/or prevention of recurrence of a gastrointestinal disorder associated with Helicobacter pylori in a patient requiring said treatment and/or prevention, which comprise administering to the patient a ther... | 12/03/2002 |
| 6455565 | Method for inhibiting skin lesion formation using histamine as the active ingredient A pharmaceutical composition of water, water soluble vinyl polymer gel, amine alcohol dispersant and IEP is used topically to treat herpes labialis and aphthous stomatitis lesions, and also to treat herpes genitalis, chicken pox, allergic conjunctivitis, ... | 09/24/2002 |
| 6444232 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present inven... | 09/03/2002 |
| 6432426 | Non-staining topical iodine composition and method Non-staining topical iodine disinfecting compositions having the ability to inactivate pathogens associated with skin infections or diseases. based upon the presence of molecular iodine in a concentration above at least 15 ppm. Any other iodine species se... | 08/13/2002 |
| 6399108 | Compositions and methods for the treatment of skin disorders The present invention is directed to methods and compositions for treating skin disorders. The present invention is easily administered and can be used for both humans and animals. The compositions of the present invention comprise borate compounds and pr... | 06/04/2002 |
| 6379651 | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases The invention relates to concomitant treatment with bismuth compounds, other antibacterial compounds, and/or antibiotics in oral-topical and peroral dosage forms to eradicate H. pylori from its niches both in the dental plaque and in the gastric mucosa in... | 04/30/2002 |
| 6372717 | Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions The invention concerns the use of peptides of general formula R1-L-Tyr-L-Arg-R2 in which R1=H or a R3-C=0 with R3=a C1 to C20 alkyl chain, linear or branched, saturated or unsaturate, hydroxylated or not, or with R3=an aryl, aryl-alkyl or alkyloxy or aryl... | 04/16/2002 |
| 6352711 | Lesion and ulcer medication Pharmaceutical compositions are provided which comprise effective amounts of antimicrobials, anti-inflammatories, and antihistamines, to provide an ulcer medication which prevents secondary infections and promotes healing while providing immediate relief ... | 03/05/2002 |
| 6261577 | Non-staining topical iodine composition and method Non-staining topical iodine disinfecting compositions having the ability to inactivate pathogens associated with skin infections or diseases. based upon the presence of molecular iodine in a concentration above at least 15 ppm. Any other iodine species se... | 07/17/2001 |
| 6258385 | Tetrasilver tetroxide treatment for skin conditions The invention relates to the use of electron active molecular crystals comprising tetrasilver tetroxide (Ag4 O4) for the treatment and cure of dermatological skin conditions (diseases) ranging from dermatitis, acne and psoiasis to he... | 07/10/2001 |
| 6254879 | Methods of treating protozoal diseases The invention concerns a new pharmaceutical agent for oral or topical administration in the treatment of protozoal diseases, in particular of leishmaniasis, which contains as the active substance one or several compounds having the general formula I ... | 07/03/2001 |
| 6190671 | Drug, particularly an immunomodulator, containing non-fructifying, non-photosynthetic filamentous bacteria envelopes or fractions thereof, and preparation thereof A drug containing, in particular, fractions of the envelopes of bacteria of genera Beggiatoa and Vitreoscilla. The drug is particularly useful for treating ear, nose and throat infections or bronchopulmonary infections.... | 02/20/2001 |
| 6166084 | Compositions for the treatment of chronic wounds The present invention provides the use of N-acetyl cysteine and its pharmaceutically acceptable salts and derivatives, for the preparation of a composition for treatment or prophylaxis of chronic ulcers. In particular, the treatment of venous ulcers, diab... | 12/26/2000 |
| 6147053 | Combination containing growth factors and polyelectrolytes The invention relates to active substance combinations which consist of at least one polypeptide with the biological action of fibroblast growth factors and of at least one cationic polyelectrolyte. These combinations permit improved dosage of the FGF act... | 11/14/2000 |
| 6110506 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present inven... | 08/29/2000 |
| 6063757 | Wound treatment method with nerve growth factor A method is provided for healing chronic wounds in a subject, particularly wounds which exhibit poor vascularization and sensory loss. The treatment method involves administering a therapeutically effective amount of ଲ-NGF to the subject to heal the... | 05/16/2000 |
| 6063817 | Use of substituted (5,6) dihydronaphthalenyl compounds having retinoid-like activity to prevent or reduce ischemic injury The present invention relates to methods of preventing, or reducing the severity of, an ischemic injury originating in an animal's dermal tissue by applying to the animal a composition comprising a compound of formula I*: ##STR1## or a nontoxic ... | 05/16/2000 |
| 6048552 | DASC compositions, process for preparing same and suspensions containing same The present invention provides DASC compositions, which upon introduction into aqueous solutions, form stable, non-gritty suspensions. The present invention also provides stable, non-gritty suspensions comprising the DASC compositions of the present inven... | 04/11/2000 |
| 6046178 | Method and compound for treating wounds with starch hydrolysate medication A medication and method for treating wounds by contacting the wound, for a sufficient period of time, with a therapeutically effective amount of a starch hydrolysate composition including trace elements, to beneficiate the wound healing processes. A possi... | 04/04/2000 |
| 6033664 | Use of a preparation comprising a plasminogen activator to improve wound healing The present invention relates to the use of non-bacterial plasminogen activators in the manufacture of a topical medical preparation for the treatment of slow- or non-healing wounds. In addition, the present invention relates to a composition comprising a... | 03/07/2000 |
| 6028062 | Use of dimeticone for the local antibacterial therapy and/or the prevention and therapy of helicobacter pylori (Hp) associated syndromes and infectious diseases The invention relates to the use of dimethylpolysiloxane (dimeticone) for the local antibacterial therapy and the prevention and treatment of syndromes and infections associated with Helicobacter pylori.... | 02/22/2000 |
| 5980915 | Process for the production of a pharmaceutical agent for oral or topical administration in the treatment of leishmaniasis The invention concerns a new pharmaceutical agent for oral or topical administration in the treatment of protozoal diseases, in particular of leishmaniasis, which contains as the active substance one or several compounds having the general formula I ... | 11/09/1999 |
| 5981497 | Utilization of sophorolipids as therapeutically active substances or cosmetic products, in particular for the treatment of the skin This invention relates to a new use of a sophorolipidic compound, of pharmaceutically acceptable salts of the acidic form of the sophorolipid, and of the ester of the deacetylated sophorolipidic acid form as therapeutically active substances in a method f... | 11/09/1999 |
| 5973007 | Use of inhibitors of retinoic acid activity for wound healing A method for promoting healing by administration of an inhibitor of the activity of retinoic acid is provided. Preferred compounds for use in such treatment include antagonists of retinoic acid. The method is particularly applicable for promoting skin hea... | 10/26/1999 |
| 5968906 | Sucralfate preparations Sucralfate containing preparations which contain both an organic acid having at least two carboxyl groups or at least one carboxyl group in the molecule and sucralfate are described. The sucralfate containing preparations have enhanced sucralfate adhesion... | 10/19/1999 |